InsidersTradesSigma
Track the Swedish Orphan Biovitrum AB (publ) stock price and the full directors' dealings record of the company, a publicly traded company based in Finland. Shares are listed on FI FI, under the authority of FIN-FSA. Operating in the Health Care sector, Swedish Orphan Biovitrum AB (publ) has logged 0 public disclosures. Market capitalisation: €161bn. Every trade is openly available.
Analysts rate Swedish Orphan Biovitrum AB (publ) Buy (bullish), based on 12 analysts. Average price target: SEK 486.67.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
0 of 0 declarations
Swedish Orphan Biovitrum AB (publ) is a pharmaceutical company focused on developing treatments for rare diseases. It is listed on the Stockholm Stock Exchange.